New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 18 04:00PM ET
163.70
Dollar change
+0.72
Percentage change
0.44
%
IndexDJIA, S&P 500 P/E17.51 EPS (ttm)9.35 Insider Own0.14% Shs Outstand2.41B Perf Week4.33%
Market Cap393.87B Forward P/E14.39 EPS next Y11.37 Insider Trans-1.16% Shs Float2.40B Perf Month7.43%
Enterprise Value407.35B PEG2.62 EPS next Q2.74 Inst Own73.60% Short Float0.66% Perf Quarter6.36%
Income22.66B P/S4.35 EPS this Y8.57% Inst Trans1.15% Short Ratio1.94 Perf Half Y12.92%
Sales90.63B P/B5.04 EPS next Y4.98% ROA11.93% Short Interest15.82M Perf YTD13.19%
Book/sh32.47 P/C10.16 EPS next 5Y6.68% ROE29.45% 52W High169.99 -3.70% Perf Year8.40%
Cash/sh16.12 P/FCF19.34 EPS past 3/5Y-9.49% 0.55% ROIC19.46% 52W Low140.68 16.36% Perf 3Y-6.69%
Dividend Est.5.05 (3.09%) EV/EBITDA14.25 Sales past 3/5Y-1.79% 1.58% Gross Margin75.44% Volatility1.86% 1.51% Perf 5Y12.73%
Dividend TTM5.02 (3.07%) EV/Sales4.49 EPS Y/Y TTM29.21% Oper. Margin23.88% ATR (14)2.79 Perf 10Y64.47%
Dividend Ex-DateAug 26, 2025 Quick Ratio1.03 Sales Y/Y TTM4.69% Profit Margin25.00% RSI (14)67.68 Recom2.24
Dividend Gr. 3/5Y5.43% 5.54% Current Ratio1.26 EPS Q/Q18.30% SMA205.08% Beta0.40 Target Price176.79
Payout84.80% Debt/Eq0.67 Sales Q/Q5.77% SMA505.99% Rel Volume1.19 Prev Close162.98
Employees138100 LT Debt/Eq0.49 EarningsJul 16 BMO SMA2005.44% Avg Volume8.15M Price163.70
IPOSep 25, 1944 Option/ShortYes / Yes EPS/Sales Surpr.3.29% 3.89% Trades Volume9,704,148 Change0.44%
Date Action Analyst Rating Change Price Target Change
May-13-25Downgrade Leerink Partners Outperform → Market Perform $153
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
Today 04:24PM
11:07AM
08:15AM
06:38AM
05:21AM
04:41AM Loading…
04:41AM
01:11AM
Jul-17-25 07:04PM
02:25PM
01:20PM
11:00AM
09:42AM
09:40AM
09:15AM
09:10AM
08:00AM Loading…
08:00AM
07:33AM
06:05AM
04:37AM
03:02AM
Jul-16-25 08:27PM
06:01PM
05:35PM
05:05PM
04:55PM
04:50PM
04:44PM
04:16PM
04:08PM
04:06PM
04:05PM Loading…
04:05PM
03:25PM
03:20PM
03:09PM
02:55PM
02:38PM
02:18PM
02:17PM
12:58PM
12:57PM
12:45PM
12:31PM
12:04PM
11:40AM
11:27AM
11:20AM
11:03AM
10:53AM
10:41AM
10:20AM
09:53AM
09:53AM
09:30AM
09:27AM
09:19AM
08:47AM
08:41AM
08:41AM
08:22AM
08:18AM
08:01AM
07:45AM
07:43AM
07:26AM
07:15AM
07:12AM
06:35AM
06:29AM
06:28AM
06:27AM
06:27AM
06:26AM
06:25AM
06:20AM
06:20AM
05:30AM
05:18AM
04:27AM
03:43AM
12:09AM
Jul-15-25 07:00PM
06:50PM
06:50PM
06:50PM
05:52PM
04:55PM
09:10AM
06:30AM
05:08AM
04:17AM
03:00AM
Jul-14-25 05:09PM
04:58PM
04:58PM
04:45PM
04:24PM
11:50AM
11:03AM
10:24AM
10:08AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED JOHN CEVP, Innovative Medicine, R&DJul 17 '25Sale163.5519,1373,129,83010,658Jul 18 04:12 PM
REED JOHN COfficerJul 17 '25Proposed Sale163.5519,1373,129,831Jul 17 04:05 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '25Option Exercise0.0025,255040,797May 05 05:10 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Option Exercise101.876,999712,98828,000Feb 26 06:42 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Sale165.886,9991,160,99421,001Feb 26 06:42 PM
Decker Robert JOfficerFeb 25 '25Proposed Sale165.886,9991,161,010Feb 25 03:05 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.002,806017,904Feb 18 09:46 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 15 '25Option Exercise0.001,029015,501Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.001,765015,111Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '25Option Exercise0.00499013,539Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 18 '25Sale156.1540362,92815,098Feb 18 09:33 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 15 '25Option Exercise0.00607091,037Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 14 '25Option Exercise0.007,367096,674Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '25Option Exercise0.00651089,603Feb 18 09:16 PM
Wolk Joseph JExec VP, CFOFeb 15 '25Option Exercise0.001,97106,113Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 14 '25Option Exercise0.0019,330020,661Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 13 '25Option Exercise0.001,77901,779Feb 18 09:13 PM
REED JOHN CEVP, Innovative Medicine, R&DFeb 15 '25Option Exercise0.001,350015,927Feb 18 09:11 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 15 '25Option Exercise0.001,5940171,110Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 14 '25Option Exercise0.0019,5180185,924Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '25Option Exercise0.001,3020167,221Feb 18 09:08 PM
Swanson James D.EVP, CIOFeb 15 '25Option Exercise0.00492016,762Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 14 '25Option Exercise0.005,079019,739Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 13 '25Option Exercise0.00447015,019Feb 18 09:06 PM
Mulholland KristenEVP, Chief HR OfficerFeb 15 '25Option Exercise0.00419013,095Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 14 '25Option Exercise0.002,608014,576Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 13 '25Option Exercise0.00411012,100Feb 18 09:05 PM
Forminard ElizabethExecutive VP, General CounselFeb 15 '25Option Exercise0.00961010,321Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 14 '25Option Exercise0.002,203011,366Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '25Option Exercise0.0065108,991Feb 18 09:03 PM
Duato JoaquinCEO and Chairman of the BoardFeb 15 '25Option Exercise0.003,6820397,525Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 14 '25Option Exercise0.0024,3350415,205Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '25Option Exercise0.003,4700392,498Feb 18 09:02 PM
Decker Robert JVP Corporate ControllerFeb 15 '25Option Exercise0.00339020,116Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 14 '25Option Exercise0.002,201021,373Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 13 '25Option Exercise0.00312019,285Feb 18 09:01 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 15 '25Option Exercise0.00492021,839Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 14 '25Option Exercise0.004,740024,591Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '25Option Exercise0.00408020,242Feb 18 08:58 PM
Duato JoaquinCEO and Chairman of the BoardFeb 07 '25Option Exercise100.06126,36912,644,482489,671Feb 11 07:43 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 07 '25Option Exercise100.0632,7623,278,166115,028Feb 11 07:42 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 07 '25Option Exercise100.0658,5045,853,910213,355Feb 11 07:41 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Option Exercise100.0613,0151,302,28113,015Feb 11 07:40 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Sale153.8913,0152,002,8780Feb 11 07:40 PM
Wolk Joseph JOfficerFeb 07 '25Proposed Sale153.8913,0152,002,924Feb 07 01:27 PM
WEINBERGER MARK ADirectorDec 12 '24Buy147.221,000147,2201,000Dec 12 05:27 PM
Hait WilliamFormer OfficerDec 04 '24Proposed Sale149.9025,7423,858,598Dec 04 01:25 PM
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM